Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP: Continuous NSAIDs + Anti-TNF in Ankylosing Spondylitis
NCT02469753Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Oct 2015
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of meloxicam in ankylosing spondylitis (AS), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Oct 2015; status: completed.
02
Drugs
meloxicam
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02469753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469753.